A. A. ESEN Et Al. , "efficacy and safety of mirabegron add on treatment to solifenacin in incontinent OAB subjects with an inadequate response to intial 4 week solifenacin monotherapy," Annual Meeting of the American-Urological-Association (AUA) , 2015
ESEN, A. A. Et Al. 2015. efficacy and safety of mirabegron add on treatment to solifenacin in incontinent OAB subjects with an inadequate response to intial 4 week solifenacin monotherapy. Annual Meeting of the American-Urological-Association (AUA) .
ESEN, A. A., drake, m., athanasiou, s., herholdt, c., saleem, t., huang, m., ... siddiqui, e.(2015). efficacy and safety of mirabegron add on treatment to solifenacin in incontinent OAB subjects with an inadequate response to intial 4 week solifenacin monotherapy . Annual Meeting of the American-Urological-Association (AUA)
ESEN, AHMET Et Al. "efficacy and safety of mirabegron add on treatment to solifenacin in incontinent OAB subjects with an inadequate response to intial 4 week solifenacin monotherapy," Annual Meeting of the American-Urological-Association (AUA), 2015
ESEN, AHMET A. Et Al. "efficacy and safety of mirabegron add on treatment to solifenacin in incontinent OAB subjects with an inadequate response to intial 4 week solifenacin monotherapy." Annual Meeting of the American-Urological-Association (AUA) , 2015
ESEN, A. A. Et Al. (2015) . "efficacy and safety of mirabegron add on treatment to solifenacin in incontinent OAB subjects with an inadequate response to intial 4 week solifenacin monotherapy." Annual Meeting of the American-Urological-Association (AUA) .
@conferencepaper{conferencepaper, author={AHMET ADİL ESEN Et Al. }, title={efficacy and safety of mirabegron add on treatment to solifenacin in incontinent OAB subjects with an inadequate response to intial 4 week solifenacin monotherapy}, congress name={Annual Meeting of the American-Urological-Association (AUA)}, city={}, country={}, year={2015}}